← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Inflame Therapeutics, Inc.
Houston, TX
$8,295,266
Total funding
5
Grants
Funding over time
peak $3.4M · FY2005–09$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$8,295,266 · 5
By mechanism
R42$5,817,079 · 2
R43$1,361,731 · 2
R44$1,116,456 · 1
Investigators at Inflame Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel CSF biomarker to predict impaired cognition in HIV$1,032,541
R42 · FY2006 · NS
Novel CSF biomarker to predict impaired cognition in HIV$1,005,479
R42 · FY2005 · NS
Development of a transgenic rat to study brain aging$895,834
R42 · FY2005 · AG
Development of a transgenic rat to study brain aging$713,574
R42 · FY2006 · AG
Designing drugs that suppress chronic brain inflammation$677,640
R43 · FY2005 · NS
Novel CSF biomarker to predict impaired cognition in HIV$586,905
R42 · FY2004 · NS
Novel CSF biomarker to predict impaired cognition in HIV$585,090
R42 · FY2004 · NS
Designing Drugs That Supress Chronic Brain InFlammation$584,944
R44 · FY2008 · NS
Development of a transgenic rat to study brain aging$548,811
R42 · FY2003 · AG
Designing Drugs That Supress Chronic Brain InFlammation$531,512
R44 · FY2009 · NS
Novel CSF biomarker to predict impaired cognition in HIV$448,845
R42 · FY2005 · NS
New drug therapy for HIV dementia$352,765
R43 · FY2004 · NS
New drug therapy for HIV dementia$331,326
R43 · FY2005 · NS